|
1
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartelink H, Horiot JC, Poortmans P,
Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J,
Jager J, Hoogenraad W, et al European Organization for Research and
Treatment of Cancer Radiotherapy and Breast Cancer Groups:
Recurrence rates after treatment of breast cancer with standard
radiotherapy with or without additional radiation. N Engl J Med.
345:1378–1387. 2001. View Article : Google Scholar
|
|
3
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG); Darby S, McGale P, Correa C, Taylor
C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J,
et al: Effect of radiotherapy after breast-conserving surgery on
10-year recurrence and 15-year breast cancer death: Meta-analysis
of individual patient data for 10,801 women in 17 randomized
trials. Lancet. 378:1707–1716. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le Scodan R, Stevens D, Brain E, Floiras
JL, Cohen-Solal C, De La Lande B, Tubiana-Hulin M, Yacoub S,
Gutierrez M, Ali D, et al: Breast cancer with synchronous
metastases: Survival impact of exclusive locoregional radiotherapy.
J Clin Oncol. 27:1375–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mattsson A, Rudén BI, Hall P, Wilking N
and Rutqvist LE: Radiation-induced breast cancer: Long-term
follow-up of radiation therapy for benign breast disease. J Natl
Cancer Inst. 85:1679–1685. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goldstein NS, Kestin L and Vicini F:
Factors associated with ipsilateral breast failure and distant
metastases in patients with invasive breast carcinoma treated with
breast-conserving therapy. A clinicopathologic study of 607
neoplasms from 583 patients. Am J Clin Pathol. 120:500–527. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Brien CJ, Smith JW, Soong SJ, Urist MM
and Maddox WA: Neck dissection with and without radiotherapy:
Prognostic factors, patterns of recurrence, and survival. Am J
Surg. 152:456–463. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vikram B, Strong EW, Shah JP and Spiro R:
Second malignant neoplasms in patients successfully treated with
multimodality treatment for advanced head and neck cancer. Head
Neck Surg. 6:734–737. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barcellos-Hoff MH and Ravani SA:
Irradiated mammary gland stroma promotes the expression of
tumorigenic potential by unirradiated epithelial cells. Cancer Res.
60:1254–1260. 2000.PubMed/NCBI
|
|
10
|
Lemay R, Archambault M, Tremblay L, Bujold
R, Lepage M and Paquette B: Irradiation of normal mouse tissue
increases the invasiveness of mammary cancer cells. Int J Radiat
Biol. 87:472–482. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bouchard G, Bouvette G, Therriault H,
Bujold R, Saucier C and Paquette B: Pre-irradiation of mouse
mammary gland stimulates cancer cell migration and development of
lung metastases. Br J Cancer. 109:1829–1838. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kozłowski J, Kozłowska A and Kocki J:
Breast cancer metastasis - insight into selected molecular
mechanisms of the phenomenon. Postepy Hig Med Dosw Online.
69:447–451. 2015. View Article : Google Scholar
|
|
15
|
Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu
J, Klijn JG, Foekens JA and Martens JW: Subtypes of breast cancer
show preferential site of relapse. Cancer Res. 68:3108–3114. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weigelt B, Glas AM, Wessels LF, Witteveen
AT, Peterse JL and van't Veer LJ: Gene expression profiles of
primary breast tumors maintained in distant metastases. Proc Natl
Acad Sci USA. 100:15901–15905. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Klein CA: Gene expression signatures,
cancer cell evolution and metastatic progression. Cell Cycle.
3:29–31. 2004. View Article : Google Scholar
|
|
18
|
Sato F, Saji S and Toi M: Genomic tumor
evolution of breast cancer. Breast Cancer. 23:4–11. 2016.
View Article : Google Scholar
|
|
19
|
Aggarwal BB, Kumar A and Bharti AC:
Anticancer potential of curcumin: Preclinical and clinical studies.
Anticancer Res. 23:363–398. 2003.PubMed/NCBI
|
|
20
|
Korutla L and Kumar R: Inhibitory effect
of curcumin on epidermal growth factor receptor kinase activity in
A431 cells. Biochim Biophys Acta. 1224:597–600. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Surh YJ, Han SS, Keum YS, Seo HJ and Lee
SS: Inhibitory effects of curcumin and capsaicin on phorbol
ester-induced activation of eukaryotic transcription factors,
NF-kappaB and AP-1. Biofactors. 12:107–112. 2000. View Article : Google Scholar
|
|
22
|
Shiri S, Alizadeh AM, Baradaran B,
Farhanghi B, Shanehbandi D, Khodayari S, Khodayari H and Tavassoli
A: Dendrosomal curcumin suppresses metastatic breast cancer in mice
by changing m1/m2 macrophage balance in the tumor microenvironment.
Asian Pac J Cancer Prev. 16:3917–3922. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Farhangi B, Alizadeh AM, Khodayari H,
Khodayari S, Dehghan MJ, Khori V, Heidarzadeh A, Khaniki M,
Sadeghiezadeh M and Najafi F: Protective effects of dendrosomal
curcumin on an animal metastatic breast tumor. Eur J Pharmacol.
758:188–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zong H, Wang F, Fan QX and Wang LX:
Curcumin inhibits metastatic progression of breast cancer cell
through suppression of urokinase-type plasminogen activator by
NF-kappa B signaling pathways. Mol Biol Rep. 39:4803–4808. 2012.
View Article : Google Scholar
|
|
25
|
Aggarwal BB, Shishodia S, Takada Y,
Banerjee S, Newman RA, Bueso-Ramos CE and Price JE: Curcumin
suppresses the paclitaxel-induced nuclear factor-kappaB pathway in
breast cancer cells and inhibits lung metastasis of human breast
cancer in nude mice. Clin Cancer Res. 11:7490–7498. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aggarwal S, Ichikawa H, Takada Y, Sandur
SK, Shishodia S and Aggarwal BB: Curcumin (diferuloylmethane)
down-regulates expression of cell proliferation and antiapoptotic
and metastatic gene products through suppression of IkappaBalpha
kinase and Akt activation. Mol Pharmacol. 69:195–206. 2006.
|
|
27
|
Shishodia S, Amin HM, Lai R and Aggarwal
BB: Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB
activation, induces G1/S arrest, suppresses proliferation, and
induces apoptosis in mantle cell lymphoma. Biochem Pharmacol.
70:700–713. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Siwak DR, Shishodia S, Aggarwal BB and
Kurzrock R: Curcumin-induced antiproliferative and proapoptotic
effects in melanoma cells are associated with suppression of
IkappaB kinase and nuclear factor kappaB activity and are
independent of the B-Raf/mitogen-activated/extracellular
signal-regulated protein kinase pathway and the Akt pathway.
Cancer. 104:879–890. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ramachandran C and You W: Differential
sensitivity of human mammary epithelial and breast carcinoma cell
lines to curcumin. Breast Cancer Res Treat. 54:269–278. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou QM, Chen QL, Du J, Wang XF, Lu YY,
Zhang H and Su SB: Synergistic effect of combinatorial treatment
with curcumin and mitomycin C on the induction of apoptosis of
breast cancer cells: A cDNA microarray analysis. Int J Mol Sci.
15:16284–16301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Calaf GM and Hei TK: Establishment of a
radiation- and estrogen-induced breast cancer model.
Carcinogenesis. 4:769–776. 2000. View Article : Google Scholar
|
|
32
|
Roy D, Calaf G and Hei TK: Profiling of
differentially expressed genes induced by high linear energy
transfer radiation in breast epithelial cells. Mol Carcinog.
31:192–203. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Calaf G and Hei TK: Oncoprotein expression
in human breast epithelial cells transformed by high-LET radiation.
Int J Radiat Biol. 77:31–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Calaf GM and Roy D: Gene and protein
expressions induced by 17β-estradiol and parathion in cultured
breast epithelial cells. Mol Med. 13:255–265. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Calaf GM, Roy D and Hei TK: Immunochemical
analysis of protein expression in breast epithelial cells
transformed by estrogens and high linear energy transfer (LET)
radiation. Histochem Cell Biol. 124:261–274. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Calaf GM, Alvarado ME and Hei TK: Beta
catenin is associated with breast cancer progression in vitro. Int
J Oncol. 26:913–921. 2005.PubMed/NCBI
|
|
37
|
Sambrook J, Fritsch EF and Maniatis T:
Molecular Cloning: A Laboratory Manual. 3rd edition. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor; NY: 1989
|
|
38
|
Liu WM, Mei R, Di X, Ryder TB, Hubbell E,
Dee S, Webster TA, Harrington CA, Ho MH, Baid J, et al: Analysis of
high density expression microarrays with signed-rank call
algorithms. Bioinformatics. 18:1593–1599. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sartorius CA, Hanna CT, Gril B, Cruz H,
Serkova NJ, Huber KM, Kabos P, Schedin TB, Borges VF, Steeg PS, et
al: Estrogen promotes the brain metastatic colonization of triple
negative breast cancer cells via an astrocyte-mediated paracrine
mechanism. Oncogene. 10:1038–1053. 2015.
|
|
40
|
Wright LE, Frye JB, Lukefahr AL,
Timmermann BN, Mohammad KS, Guise TA and Funk JL: Curcuminoids
block TGF-β signaling in human breast cancer cells and limit
osteolysis in a murine model of breast cancer bone metastasis. J
Nat Prod. 76:316–321. 2013. View Article : Google Scholar
|
|
41
|
Ferreira LC, Arbab AS, Jardim-Perassi BV,
Borin TF, Varma NR, Iskander AS, Shankar A, Ali MM and Zuccari DA:
Effect of curcumin on pro-angiogenic factors in the xenograft model
of breast cancer. Anticancer Agents Med Chem. 15:1285–1296. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang W, Sukamtoh E, Xiao H and Zhang G:
Curcumin inhibits lymphangiogenesis in vitro and in vivo. Mol Nutr
Food Res. 59:2345–2354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mohankumar K, Pajaniradje S, Sridharan S,
Singh VK, Ronsard L, Banerjea AC, Benson CS, Coumar MS and
Rajagopalan R: Mechanism of apoptotic induction in human breast
cancer cell, MCF-7, by an analog of curcumin in comparison with
curcumin - an in vitro and in silico approach. Chem Biol Interact.
210:51–63. 2014. View Article : Google Scholar
|
|
44
|
Thaloor D, Singh AK, Sidhu GS, Prasad PV,
Kleinman HK and Maheshwari RK: Inhibition of angiogenic
differentiation of human umbilical vein endothelial cells by
curcumin. Cell Growth Differ. 9:305–312. 1998.PubMed/NCBI
|
|
45
|
Mitra A, Chakrabarti J, Banerji A,
Chatterjee A and Das BR: Curcumin, a potential inhibitor of MMP-2
in human laryngeal squamous carcinoma cells HEp2. J Environ Pathol
Toxicol Oncol. 25:679–690. 2006. View Article : Google Scholar
|
|
46
|
Prud'homme GJ: Cancer stem cells and novel
targets for antitumor strategies. Review. Curr Pharm Des.
18:2838–2849. 2012. View Article : Google Scholar
|
|
47
|
Sun T, Jiang D, Zhang L, Su Q, Mao W and
Jiang C: Expression profile of cathepsins indicates the potential
of cathepsins B and D as prognostic factors in breast cancer
patients. Oncol Lett. 11:575–583. 2016.PubMed/NCBI
|
|
48
|
Ruan H, Hao S, Young P and Zhang H:
Targeting cathepsin B for cancer therapies. Horiz Cancer Res.
56:23–40. 2015.PubMed/NCBI
|
|
49
|
Chen CC, Sureshbabul M, Chen HW, Lin YS,
Lee JY, Hong QS, Yang YC and Yu SL: Curcumin suppresses metastasis
via Sp-1, FAK inhibition, and E-Cadherin upregulation in colorectal
cancer. Evid Based Complement Alternat Med.
2013:5416952013.PubMed/NCBI
|
